FDA clears Bos Sci stent for 2.25mm heart vessels
Boston Scientific has received approval from the FDA to market its Taxus Liberte Atom paclitaxel-eluting coronary stent system, a drug-eluting stent (DES) designed for treating small coronary vessels, as small as 2.25 mm in diameter.
The Taxus Liberte Atom joins the Taxus Express Atom stent as the only DES approved for small vessel use in the U.S. The Natick, Mass.-based company plans to begin a full U.S. launch of Taxus Liberte Atom next month.
Boston Scientific also said that it hopes to expand its stent portfolio later this year with a 38 mm long DES, the Taxus Liberte long stent, which is currently under review with the FDA.
The Taxus Liberte Atom joins the Taxus Express Atom stent as the only DES approved for small vessel use in the U.S. The Natick, Mass.-based company plans to begin a full U.S. launch of Taxus Liberte Atom next month.
Boston Scientific also said that it hopes to expand its stent portfolio later this year with a 38 mm long DES, the Taxus Liberte long stent, which is currently under review with the FDA.